Abstract
Cone snails have evolved many 1000s of small, structurally stable venom peptides (conopeptides) for prey capture and defense. Whilst <0.1% have been pharmacologically characterised, those with known function typically target membrane proteins of therapeutic importance, including ion channels, transporters and GPCRs. Several conopeptides reduce pain in animals models, with one in clinical development (χ-conopeptide analogue Xen2174) and one marketed (ω- conotoxin MVIIA or Prialt) for the treatment of severe pain. In addition to their therapeutic potential, conopeptides have been valuable probes for studying the role of a number of key membrane proteins in normal and disease physiology.
Keywords: Conopeptides, ion channels, GPCR, Cone snails, venom peptides, target membrane proteins, membrane proteins, disease physiology, pharmacologies, peptide mimetic, globular peptide, conotoxin, complex venoms, pharmacological targets, neurological targets
Current Topics in Medicinal Chemistry
Title:Therapeutic Potential of Cone Snail Venom Peptides (Conopeptides)
Volume: 12 Issue: 14
Author(s): Irina Vetter and Richard J. Lewis
Affiliation:
Keywords: Conopeptides, ion channels, GPCR, Cone snails, venom peptides, target membrane proteins, membrane proteins, disease physiology, pharmacologies, peptide mimetic, globular peptide, conotoxin, complex venoms, pharmacological targets, neurological targets
Abstract: Cone snails have evolved many 1000s of small, structurally stable venom peptides (conopeptides) for prey capture and defense. Whilst <0.1% have been pharmacologically characterised, those with known function typically target membrane proteins of therapeutic importance, including ion channels, transporters and GPCRs. Several conopeptides reduce pain in animals models, with one in clinical development (χ-conopeptide analogue Xen2174) and one marketed (ω- conotoxin MVIIA or Prialt) for the treatment of severe pain. In addition to their therapeutic potential, conopeptides have been valuable probes for studying the role of a number of key membrane proteins in normal and disease physiology.
Export Options
About this article
Cite this article as:
Vetter Irina and J. Lewis Richard, Therapeutic Potential of Cone Snail Venom Peptides (Conopeptides), Current Topics in Medicinal Chemistry 2012; 12 (14) . https://dx.doi.org/10.2174/156802612802652457
DOI https://dx.doi.org/10.2174/156802612802652457 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic:Stabilizing the Vulnerable Plaque: The Search for the Magic Bullet (Executive Editors: G. Pasterkamp and M. Daemen)]
Current Pharmaceutical Design Fluorescence-Guided Malignant Glioma Resections
Current Drug Discovery Technologies Pathogenesis and Immune Status in COVID-19 Pneumonia - A Minireview
Coronaviruses Pharmacological Management of Dysphagia in Patients with Alzheimer’s Disease: A Narrative Review
Current Alzheimer Research Atrial Tachycardias Following Atrial Fibrillation Ablation
Current Cardiology Reviews Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
Current Pharmaceutical Design Gender Bias in Acute Coronary Syndromes
Current Vascular Pharmacology Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design Pharmacokinetics/Pharmacodynamics Model-Supported Early Drug Development
Current Pharmaceutical Biotechnology Editorial (Hot Topics: Cardiovascular Dysfunction in Sepsis: From Basic Mechanisms to Clinical Management)
Current Vascular Pharmacology The Potential of Lifestyle Changes for Improving the Clinical Outcome of Patients with Coronary Heart Disease: Mechanisms of Benefit and Clinical Results
Reviews on Recent Clinical Trials Vitamin D in Chronic Kidney Disease: New Potential for Intervention
Current Drug Targets Human Ether-a-Go-Go-Related Gene Channel Blockers and its Structural Analysis for Drug Design
Current Drug Targets The Antitumor Effects of Icaritin Against Breast Cancer is Related to Estrogen Receptors
Current Molecular Medicine Potential of Resveratrol in Preventing the Development of Heart Failure
Current Chemical Biology The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
Cardiovascular & Hematological Disorders-Drug Targets Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
Current Pharmaceutical Design Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS
Current Medicinal Chemistry Role of AGEs-RAGE System in Cardiovascular Disease
Current Pharmaceutical Design